Skip to main content

Table 2 Baseline clinical data

From: Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study

Variable Mean ± SD (Range) Insulin (n = 8) Sulfonylurea (n = 5) Metformin (n = 6) Thiazoli-dinediones (n = 6) P Value
Age (Yrs) 26.0 ± 10.3 (13 – 44) 24.4 ± 6.9 (17 – 33) 22.8 ± 6.7 (15 – 35) 34.0 ± 9.9 (20 – 49) 0.166
ALT (U/L) 65.1 ± 24.1 (25 – 99) 42.0 ± 26.5 (14 – 73) 68.3 ± 28.1 (28 – 107 67.4 ± 8.4 (55 – 76) (n = 5) 0.250
FEV1 (%) 56.8 ± 28.0 (18 – 99) 53.0 ± 23.3 (30 – 83) 79.2 ± 34.5 (17 – 117) 52.0 ± 25.2 (3 – 92) 0.329
Weight (kg) 60.2 ± 12.9 (41.9 – 81.5) 66.0 ± 24.8 (33.6 – 97.5) 61.8 ± 12.2 (41.8 – 71.1) 65.7 ± 20.4 (44.4 – 96.5) 0.911
HbA1c 9.5 ± 2.6 (5.5 – 14.3) 7.2 ± 0.8 (6.3 – 8.1) 8.8 ± 2.8 (5.4 – 13.3) 8.0 ± 3.1 (5.1 – 13.3) 0.408
Treatment Duration (Yrs) 4.8 ± 2.9 (2 – 10) 1.8 ± 1.3 (1 – 4) 2.7 ± 1.4 (1 – 5) 1.8 ± 0.4 (1 – 2) 0.093
  1. SD, standard deviation; Yrs, years; ALT, alanine aminotransferase; FEV1, forced expiratory volume at 1 second; HbA1c, percent glycosylated hemoglobin. P values for Age, ALT, FEV1, Weight, and HbA1c are from one-way analysis of variance (ANOVA); the P value for Treatment Duration is from Welch ANOVA for unequal group variances.